Cornerstone Therapeutics, Oscient deal

By WIR Staff | Jul 20, 2009 | 7:00 AM GMT

On July 13, Oscient filed Chapter 11 Bankruptcy and said it plans to sell to Cornerstone its assets related to Factive gemifloxacin mesylate. Oscient will receive